Fabre-Kramer Pharmaceuticals

Fabre-Kramer Pharmaceuticals is a leader in identifying, developing, and commercializing psychiatric drugs for the treatment of mental and neurological disorders. Its product Exxua (extended-release gepirone hydrochloride tablets) has been FDA-approved for the treatment of Major Depressive Disorder (MDD) in adults.